290 related articles for article (PubMed ID: 19542943)
1. Progressive osteoblastic bone metastases in breast cancer negative on FDG-PET.
Huyge V; Garcia C; Vanderstappen A; Alexiou J; Gil T; Flamen P
Clin Nucl Med; 2009 Jul; 34(7):417-20. PubMed ID: 19542943
[TBL] [Abstract][Full Text] [Related]
2. Pitfalls of FDG-PET for the diagnosis of osteoblastic bone metastases in patients with breast cancer.
Nakai T; Okuyama C; Kubota T; Yamada K; Ushijima Y; Taniike K; Suzuki T; Nishimura T
Eur J Nucl Med Mol Imaging; 2005 Nov; 32(11):1253-8. PubMed ID: 16133397
[TBL] [Abstract][Full Text] [Related]
3. Fusion of metabolic function and morphology: sequential [18F]fluorodeoxyglucose positron-emission tomography/computed tomography studies yield new insights into the natural history of bone metastases in breast cancer.
Du Y; Cullum I; Illidge TM; Ell PJ
J Clin Oncol; 2007 Aug; 25(23):3440-7. PubMed ID: 17592153
[TBL] [Abstract][Full Text] [Related]
4. Bone metastases from breast cancer: associations between morphologic CT patterns and glycolytic activity on PET and bone scintigraphy as well as explorative search for influential factors.
Sugihara T; Koizumi M; Koyama M; Terauchi T; Gomi N; Ito Y; Hatake K; Sata N
Ann Nucl Med; 2017 Dec; 31(10):719-725. PubMed ID: 28864931
[TBL] [Abstract][Full Text] [Related]
5. Comparison of FDG-PET/CT and bone scintigraphy for detection of bone metastases in breast cancer.
Hahn S; Heusner T; Kümmel S; Köninger A; Nagarajah J; Müller S; Boy C; Forsting M; Bockisch A; Antoch G; Stahl A
Acta Radiol; 2011 Nov; 52(9):1009-14. PubMed ID: 21969709
[TBL] [Abstract][Full Text] [Related]
6. Clinical relevance of 18F-FDG-negative osteoblastic metastatic bone lesions noted on PET/CT in breast cancer patients.
Al-Muqbel KM; Yaghan RJ; Al-Omari MH; Rousan LA; Dagher NM; Al Bashir S
Nucl Med Commun; 2016 Jun; 37(6):593-601. PubMed ID: 26813990
[TBL] [Abstract][Full Text] [Related]
7. Positron emission tomography and bone metastases.
Fogelman I; Cook G; Israel O; Van der Wall H
Semin Nucl Med; 2005 Apr; 35(2):135-42. PubMed ID: 15765376
[TBL] [Abstract][Full Text] [Related]
8. Improved detection of bone metastases from lung cancer in the thoracic cage using 5- and 1-mm axial images versus a new CT software generating rib unfolding images: comparison with standard ¹⁸F-FDG-PET/CT.
Homann G; Mustafa DF; Ditt H; Spengler W; Kopp HG; Nikolaou K; Horger M
Acad Radiol; 2015 Apr; 22(4):505-12. PubMed ID: 25586709
[TBL] [Abstract][Full Text] [Related]
9. Comparison of FDG PET and SPECT for detection of bone metastases in breast cancer.
Uematsu T; Yuen S; Yukisawa S; Aramaki T; Morimoto N; Endo M; Furukawa H; Uchida Y; Watanabe J
AJR Am J Roentgenol; 2005 Apr; 184(4):1266-73. PubMed ID: 15788608
[TBL] [Abstract][Full Text] [Related]
10. Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions.
Cook GJ; Houston S; Rubens R; Maisey MN; Fogelman I
J Clin Oncol; 1998 Oct; 16(10):3375-9. PubMed ID: 9779715
[TBL] [Abstract][Full Text] [Related]
11. 18F sodium fluoride PET/CT detects osseous metastases from breast cancer missed on FDG PET/CT with marrow rebound.
Avery R; Kuo PH
Clin Nucl Med; 2013 Sep; 38(9):746-8. PubMed ID: 23797230
[TBL] [Abstract][Full Text] [Related]
12. FDG-avid sclerotic bone metastases in breast cancer patients: a PET/CT case series.
Koolen BB; Vegt E; Rutgers EJ; Vogel WV; Stokkel MP; Hoefnagel CA; Fioole-Bruining A; Vrancken Peeters MJ; Valdés Olmos RA
Ann Nucl Med; 2012 Jan; 26(1):86-91. PubMed ID: 21953212
[TBL] [Abstract][Full Text] [Related]
13. Disseminated osteomyelitis or bone metastases of breast cancer: (18)F-FDG-PET/CT helps unravel an unusual presentation.
Mandegaran R; Debard A; Alvarez M; Marchou B; Massip P; Wagner T
Ann Nucl Med; 2014 Feb; 28(2):167-71. PubMed ID: 24203488
[TBL] [Abstract][Full Text] [Related]
14. 18F-FDG PET/CT findings and circulating tumor cell counts in the monitoring of systemic therapies for bone metastases from breast cancer.
De Giorgi U; Mego M; Rohren EM; Liu P; Handy BC; Reuben JM; Macapinlac HA; Hortobagyi GN; Cristofanilli M; Ueno NT
J Nucl Med; 2010 Aug; 51(8):1213-8. PubMed ID: 20660382
[TBL] [Abstract][Full Text] [Related]
15. Detection of bone metastases in breast cancer by positron emission tomography.
Schirrmeister H
Radiol Clin North Am; 2007 Jul; 45(4):669-76, vi. PubMed ID: 17706531
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of 18F-FDG-PET/CT vs Bone Scintigraphy in Treatment Response Assessment of Bone Metastases in Breast Cancer.
Al-Muqbel KM; Yaghan RJ
Medicine (Baltimore); 2016 May; 95(21):e3753. PubMed ID: 27227942
[TBL] [Abstract][Full Text] [Related]
17. F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging.
Gallowitsch HJ; Kresnik E; Gasser J; Kumnig G; Igerc I; Mikosch P; Lind P
Invest Radiol; 2003 May; 38(5):250-6. PubMed ID: 12750613
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of bone scintigraphy and (18)F-FDG PET/CT in bone metastases of lung cancer patients].
Portilla-Quattrociocchi H; Banzo I; Martínez-Rodríguez I; Quirce R; Jiménez-Bonilla J; de Arcocha Torres M; Medina-Quiroz P; del Castillo R; Rubio-Vassallo A; Carril JM
Rev Esp Med Nucl; 2011; 30(1):2-7. PubMed ID: 21208693
[TBL] [Abstract][Full Text] [Related]
19. Discordant findings in patients with non-small-cell lung cancer: absolutely normal bone scans versus disseminated bone metastases on positron-emission tomography/computed tomography.
Ak I; Sivrikoz MC; Entok E; Vardareli E
Eur J Cardiothorac Surg; 2010 Apr; 37(4):792-6. PubMed ID: 20015657
[TBL] [Abstract][Full Text] [Related]
20. [Heterogeneity of bone metastases in a patient with breast cancer: case report illustrating the potential of combining various imaging techniques].
Withofs N; Collignon J; Rorive A; Jerusalem G; Hustinx R
Rev Med Liege; 2011; 66(5-6):288-90. PubMed ID: 21826964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
